Bone Density Loss: Tenofovir has been related to a lower in bone mineral density, rising the chance of bone difficulties or fractures.Administration of significant doses of tenofovir continues to be reported to supply bone toxicity described as osteomalacia and diminished bone mineral density and to produce some diploma of renal toxicity.Dolutegrav